Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below Two Hundred Day Moving Average of $1.65

Predictive Oncology Inc. (NASDAQ:POAI) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.65 and traded as low as $0.90. Predictive Oncology shares last traded at $0.91, with a volume of 26,789 shares.

Analysts Set New Price Targets

Separately, HC Wainwright began coverage on Predictive Oncology in a research report on Monday, August 19th. They set a “buy” rating and a $3.00 price target for the company.

Predictive Oncology Price Performance

The stock has a market capitalization of $6.10 million, a PE ratio of -0.25 and a beta of 1.13. The stock’s fifty day moving average is $1.04 and its 200-day moving average is $1.65.

Predictive Oncology (NASDAQ:POAI) last issued its quarterly earnings data on Tuesday, August 13th. The medical instruments supplier reported ($0.68) earnings per share for the quarter. Predictive Oncology had a negative return on equity of 200.06% and a negative net margin of 802.69%. The firm had revenue of $0.28 million during the quarter. On average, analysts forecast that Predictive Oncology Inc. will post -2.03 EPS for the current year.

About Predictive Oncology

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.